Welcome,

​

Learning From Market Leaders
At KIC Ventures, we’ve spent the past 15 years building a private equity healthtech investment firm on the foundation of entrepreneurship, resilience, and innovation. Inspired by niche market leaders like Arthrex in outpatient orthopedic arthroscopic surgery—founded on a $60,000 personal investment and now valued at over $10 billion—we share their commitment to surgeon education and relentless innovation. Similarly, Vista Equity Partners, founded by Robert Smith and now managing over $100 billion in assets, exemplifies the power of private equity majority ownership, a model KIC has embraced since 2000.

​

Reshaping Private Equity in Healthtech
We are proud to share that KIC Ventures is reshaping private equity in healthtech by maintaining majority ownership in the most revenue-generating portfolio of spine companies (10+) in the world. With assets under management estimated between $1 - $3 billion and growing, our "3 P’s" entrepreneurial philosophy—identifying problems, predicting future needs, and creating products that drive global adoption—has fueled our growth. Our proprietary Less Exposure Spine Surgery (LESS) philosophy focuses on LESS invasive procedures that restore and preserve anatomy, reduce recovery times, and empower physicians.

​

Educating Future Leaders in Spine Care
We are dedicated to training the next generation of spine care leaders. In 2019, we began educating interventional pain management (IPM) and interventional radiology (IR) physicians, transitioning them from pain modulation to performing interventional spine procedures. This shift parallels the evolution of cardiologists into interventional specialists, and we believe these physicians will shape the future of outpatient spine care.

​

Growth and Vision for the Future
Our strategic acquisitions, such as AxioMed’s viscoelastic total disc replacement and NanoFuse’s 45S5 Bioglass ceramic synthetic biologics, along with the development of the MANTIS percutaneous pedicle screw system (acquired by Stryker), have laid the foundation for our success. With new product launches on the horizon, we’re set to continue leading the transformation of outpatient spine surgery worldwide.

​

Join Us on This Journey
Our goal is to reach a $5 billion valuation within the next five years, and we invite you to join us on this exciting journey. With a minimum investment of $30,000 at $60.00 per share, act now before we close the Series A round and multiply our valuation.

 

Sincerely,

 

Kingsley R Chin MD MBA